75
Participants
Start Date
May 14, 2025
Primary Completion Date
January 31, 2027
Study Completion Date
January 31, 2027
GS-0151
Administered for 12 weeks
Placebo
Administered for 12 weeks
RECRUITING
Altoona Center for Clinical Research, Duncansville
RECRUITING
Tidewater Clinical Research, LLC/ Virginia Rheumatology Clinic, Virginia Beach
RECRUITING
Clinical Research of West Florida, Inc, Clearwater
RECRUITING
Pinnacle Research Group, LLC, Anniston
RECRUITING
DM Clinical Research, Melrose Park
RECRUITING
Great Lakes Clinical Trials dba Flourish Research Chicago, Chicago
RECRUITING
Accurate Clinical Research, Inc, Lake Charles
RECRUITING
Lynn Health Science Institute, Oklahoma City
RECRUITING
Accurate Clinical Research, Inc, Houston
RECRUITING
Accurate Clinical Management, LLC, Baytown
RECRUITING
Clinical Trials of Texas LLC, dba Flourish Research, San Antonio
RECRUITING
Medvin Clinical Research, Whittier
RECRUITING
Medvin Clinical Research, Tujunga
RECRUITING
University of California, San Diego, La Jolla
RECRUITING
Stanford University School of Medicine, Palo Alto
RECRUITING
ARENSIA Exploratory Medicine, LLC, Tbilisi
RECRUITING
"Republican Clinical Hospital Timofei Mosneaga, Arensia EM", Chisinau
Lead Sponsor
Gilead Sciences
INDUSTRY